bpc 157 tendonitis bpc-157 animal studies tendon repair Stable Gastric Pentadecapeptide as a Therapy for the Disable Myotendinous Junctions in Rats BPC-157 for Tendon and Ligament – bpc-157 vs other peptides for

The product page notes that each batch undergoes analytical verification to confirm molecular identity, purity, and structural consistency of all included components

The primary mechanisms of action include: Enhancing glucose-dependent insulin secretion from pancreatic beta cells, which helps lower blood glucose levels when they are elevated Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production [1] [2] Slowing gastric emptying , which moderates the rate at which nutrients enter the bloodstream Promoting satiety through central nervous system pathways, leading to reduced caloric intake [1] [2] These medications are peptide-based (and one fusion protein) and are temperature sensitive

Here is what the evidence says, clearly and without exaggeration

The protein expression and activation of FAK and paxillin were determined by Western blot analysis, and the phosphorylation levels of both FAK and paxillin were dose dependently increased by BPC 157 while the total amounts of protein was unaltered